Latest Insider Transactions at Aerovate Therapeutics, Inc. (AVTE)
This section provides a real-time view of insider transactions for Aerovate Therapeutics, Inc. (AVTE). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Aerovate Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Aerovate Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 05
2023
|
Ralph Niven CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
2,250
-32.31%
|
$38,250
$17.55 P/Share
|
|
Jul 05
2023
|
Ralph Niven CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,250
+25.83%
|
$2,250
$1.94 P/Share
|
|
Jul 03
2023
|
Timothy P Noyes CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
10,000
-100.0%
|
$180,000
$18.0 P/Share
|
|
Jul 03
2023
|
Timothy P Noyes CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$20,000
$2.14 P/Share
|
|
Jun 06
2023
|
Benjamin T Dake |
SELL
Open market or private sale
|
Direct |
10,283
-44.93%
|
$164,528
$16.63 P/Share
|
|
Jun 06
2023
|
Benjamin T Dake |
BUY
Exercise of conversion of derivative security
|
Direct |
10,283
+39.96%
|
$10,283
$1.94 P/Share
|
|
Jun 05
2023
|
Ralph Niven CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
2,250
-58.31%
|
$36,000
$16.26 P/Share
|
|
Jun 05
2023
|
Ralph Niven CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,250
+25.83%
|
$2,250
$1.94 P/Share
|
|
May 19
2023
|
Hunter Gillies CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
65
-1.96%
|
$1,235
$19.5 P/Share
|
|
May 19
2023
|
Hunter Gillies CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
65
+1.92%
|
$65
$1.74 P/Share
|
|
May 17
2023
|
Hunter Gillies CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,090
-25.11%
|
$20,710
$19.59 P/Share
|
|
May 17
2023
|
Hunter Gillies CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,090
+20.07%
|
$1,090
$1.74 P/Share
|
|
May 08
2023
|
Benjamin T Dake |
SELL
Open market or private sale
|
Direct |
10,284
-65.18%
|
$226,248
$22.18 P/Share
|
|
May 08
2023
|
Benjamin T Dake |
BUY
Exercise of conversion of derivative security
|
Direct |
10,284
+39.96%
|
$10,284
$1.94 P/Share
|
|
May 05
2023
|
Ralph Niven CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
2,250
-32.15%
|
$47,250
$21.21 P/Share
|
|
May 05
2023
|
Ralph Niven CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,250
+25.83%
|
$2,250
$1.94 P/Share
|
|
May 03
2023
|
Marinus Verwijs CHIEF TECHNICAL OFFICER |
SELL
Open market or private sale
|
Direct |
759
-100.0%
|
$15,180
$20.79 P/Share
|
|
May 02
2023
|
Timothy P Noyes CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
693
-100.0%
|
$14,553
$21.15 P/Share
|
|
May 01
2023
|
Timothy P Noyes CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
15,000
-95.58%
|
$300,000
$20.61 P/Share
|
|
May 01
2023
|
Timothy P Noyes CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+48.87%
|
$30,000
$2.14 P/Share
|
|
Apr 21
2023
|
Hunter Gillies CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
4,000
-67.11%
|
$76,000
$19.5 P/Share
|
|
Apr 21
2023
|
Hunter Gillies CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+40.16%
|
$4,000
$1.74 P/Share
|
|
Apr 06
2023
|
Benjamin T Dake |
SELL
Open market or private sale
|
Direct |
10,283
-100.0%
|
$185,094
$18.17 P/Share
|
|
Apr 06
2023
|
Benjamin T Dake |
BUY
Exercise of conversion of derivative security
|
Direct |
10,283
+46.68%
|
$10,283
$1.94 P/Share
|
|
Apr 05
2023
|
Ralph Niven CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
2,250
-34.7%
|
$40,500
$18.51 P/Share
|
|
Apr 05
2023
|
Ralph Niven CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,250
+25.83%
|
$2,250
$1.94 P/Share
|
|
Apr 03
2023
|
Timothy P Noyes CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
15,000
-80.57%
|
$285,000
$19.47 P/Share
|
|
Apr 03
2023
|
Timothy P Noyes CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$30,000
$2.14 P/Share
|
|
Mar 06
2023
|
Ralph Niven CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
2,250
-29.93%
|
$54,000
$24.33 P/Share
|
|
Mar 06
2023
|
Ralph Niven CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,250
+25.83%
|
$2,250
$1.94 P/Share
|
|
Mar 06
2023
|
Benjamin T Dake |
SELL
Open market or private sale
|
Direct |
10,282
-98.95%
|
$246,768
$24.11 P/Share
|
|
Mar 06
2023
|
Benjamin T Dake |
BUY
Exercise of conversion of derivative security
|
Direct |
10,282
+46.68%
|
$10,282
$1.94 P/Share
|
|
Mar 01
2023
|
Timothy P Noyes CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
15,000
-63.2%
|
$360,000
$24.22 P/Share
|
|
Mar 01
2023
|
Timothy P Noyes CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$30,000
$2.14 P/Share
|
|
Feb 06
2023
|
Ralph Niven CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
2,250
-58.31%
|
$54,000
$24.27 P/Share
|
|
Feb 06
2023
|
Ralph Niven CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,250
+25.83%
|
$2,250
$1.94 P/Share
|
|
Feb 06
2023
|
Benjamin T Dake |
SELL
Open market or private sale
|
Direct |
10,284
-93.07%
|
$246,816
$24.77 P/Share
|
|
Feb 06
2023
|
Benjamin T Dake |
BUY
Exercise of conversion of derivative security
|
Direct |
10,284
+46.68%
|
$10,284
$1.94 P/Share
|
|
Feb 01
2023
|
Timothy P Noyes CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
15,000
-85.02%
|
$330,000
$22.79 P/Share
|
|
Feb 01
2023
|
Timothy P Noyes CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$30,000
$2.14 P/Share
|
|
Jan 06
2023
|
Benjamin T Dake |
SELL
Open market or private sale
|
Direct |
10,284
-86.43%
|
$267,384
$26.29 P/Share
|
|
Jan 06
2023
|
Benjamin T Dake |
BUY
Exercise of conversion of derivative security
|
Direct |
10,284
+46.68%
|
$10,284
$1.94 P/Share
|
|
Jan 05
2023
|
Ralph Niven CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
2,250
-58.31%
|
$58,500
$26.4 P/Share
|
|
Jan 05
2023
|
Ralph Niven CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,250
+25.83%
|
$2,250
$1.94 P/Share
|
|
Jan 03
2023
|
Timothy P Noyes CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
15,000
-87.86%
|
$420,000
$28.33 P/Share
|
|
Jan 03
2023
|
Timothy P Noyes CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$30,000
$2.14 P/Share
|
|
Dec 12
2022
|
Benjamin T Dake |
SELL
Open market or private sale
|
Direct |
2,059
-52.16%
|
$57,652
$28.3 P/Share
|
|
Dec 12
2022
|
Benjamin T Dake |
BUY
Exercise of conversion of derivative security
|
Direct |
2,059
+50.0%
|
$4,118
$2.14 P/Share
|
|
Dec 12
2022
|
George A Eldridge |
SELL
Open market or private sale
|
Direct |
10,000
-83.61%
|
$300,000
$30.04 P/Share
|
|
Dec 12
2022
|
George A Eldridge |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+45.54%
|
$20,000
$2.14 P/Share
|